行情

RMD

RMD

瑞思迈
NYSE

实时行情|Nasdaq Last Sale

153.63
+1.38
+0.91%
盘后: 153.63 0 0.00% 16:10 12/13 EST
开盘
151.43
昨收
152.25
最高
153.96
最低
151.31
成交量
58.39万
成交额
--
52周最高
153.96
52周最低
90.64
市值
220.90亿
市盈率(TTM)
52.28
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

RMD 新闻

  • Globus Medical Announces Board of Director Addition and Departure
  • GlobeNewswire.1天前
  • Neogen's Food Safety Business Thrives on Ergot Alkaloids Test
  • Zacks.1天前
  • The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
  • Benzinga.1天前
  • Bruker Launches Luxendo TruLive3D Imager, Expands NANO Arm (Revised)
  • Zacks.1天前

更多

所属板块

先进医疗设备和技术
+0.10%
医疗设备和用品
+0.24%

热门股票

名称
价格
涨跌幅

RMD 简况

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.
展开

Webull提供ResMed Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。